A lágyrészszarkóma epidemiológiája egy hazai egyetemi centrumban

Maysam Amin Moghaddam, Tamás Perlaky, Krisztián Kovács, János Kiss, Krisztián Szalay, I. Antal, Z. Sápi, M. Szendrői

Research output: Article

Abstract

Our aim was to investigate the rare malignant soft tissue sarcomas responsible for 1.5% of all malignant tumors, to compare our epidemiological data from the patient population of the Department of Orthopaedics, Semmelweis University, to data described in the international literature for soft tissue tumors. We reviewed 595 cases of primary soft tissue sarcomas treated between 1994 and 2014 and compared results to international data from the literature. Our results were similar to those found in the international literature: mean age, mild male predominance, the most common sarcoma subgroups, the superficial and deep sarcoma ratio, low and high grade sarcoma ratio, the ratio of patients with a primary lung metastasis. Compared to other European data we found significantly longer patient referral to centers (3.6 months in case of superficial sarcomas, 8 months in case of deep localization) which surprisingly had no substantial effect on average tumor size (superficial: 5 cm, deep: 10.5 cm). This corresponds with data from the literature. The long delay period in patients' request of medical service draws attention to difficulties in differential diagnosis in this rare type of tumor, delays in referring patients to a center, and the lack of consultation. We recommend that the required investigations be performed in a musculoskeletal oncology center where this type of cancer is treated.

Original languageHungarian
Pages (from-to)368-373
Number of pages6
JournalMagyar onkologia
Volume61
Issue number4
Publication statusPublished - dec. 18 2017

Fingerprint

Hungary
Sarcoma
Epidemiology
Neoplasms
Referral and Consultation
Orthopedics
Differential Diagnosis
Neoplasm Metastasis
Lung
Population

ASJC Scopus subject areas

  • Medicine(all)

Cite this

Moghaddam, M. A., Perlaky, T., Kovács, K., Kiss, J., Szalay, K., Antal, I., ... Szendrői, M. (2017). A lágyrészszarkóma epidemiológiája egy hazai egyetemi centrumban. Magyar onkologia, 61(4), 368-373.

A lágyrészszarkóma epidemiológiája egy hazai egyetemi centrumban. / Moghaddam, Maysam Amin; Perlaky, Tamás; Kovács, Krisztián; Kiss, János; Szalay, Krisztián; Antal, I.; Sápi, Z.; Szendrői, M.

In: Magyar onkologia, Vol. 61, No. 4, 18.12.2017, p. 368-373.

Research output: Article

Moghaddam, MA, Perlaky, T, Kovács, K, Kiss, J, Szalay, K, Antal, I, Sápi, Z & Szendrői, M 2017, 'A lágyrészszarkóma epidemiológiája egy hazai egyetemi centrumban', Magyar onkologia, vol. 61, no. 4, pp. 368-373.
Moghaddam MA, Perlaky T, Kovács K, Kiss J, Szalay K, Antal I et al. A lágyrészszarkóma epidemiológiája egy hazai egyetemi centrumban. Magyar onkologia. 2017 dec. 18;61(4):368-373.
Moghaddam, Maysam Amin ; Perlaky, Tamás ; Kovács, Krisztián ; Kiss, János ; Szalay, Krisztián ; Antal, I. ; Sápi, Z. ; Szendrői, M. / A lágyrészszarkóma epidemiológiája egy hazai egyetemi centrumban. In: Magyar onkologia. 2017 ; Vol. 61, No. 4. pp. 368-373.
@article{6e6affcca41349b793f6ac3d813a4db4,
title = "A l{\'a}gyr{\'e}szszark{\'o}ma epidemiol{\'o}gi{\'a}ja egy hazai egyetemi centrumban",
abstract = "Our aim was to investigate the rare malignant soft tissue sarcomas responsible for 1.5{\%} of all malignant tumors, to compare our epidemiological data from the patient population of the Department of Orthopaedics, Semmelweis University, to data described in the international literature for soft tissue tumors. We reviewed 595 cases of primary soft tissue sarcomas treated between 1994 and 2014 and compared results to international data from the literature. Our results were similar to those found in the international literature: mean age, mild male predominance, the most common sarcoma subgroups, the superficial and deep sarcoma ratio, low and high grade sarcoma ratio, the ratio of patients with a primary lung metastasis. Compared to other European data we found significantly longer patient referral to centers (3.6 months in case of superficial sarcomas, 8 months in case of deep localization) which surprisingly had no substantial effect on average tumor size (superficial: 5 cm, deep: 10.5 cm). This corresponds with data from the literature. The long delay period in patients' request of medical service draws attention to difficulties in differential diagnosis in this rare type of tumor, delays in referring patients to a center, and the lack of consultation. We recommend that the required investigations be performed in a musculoskeletal oncology center where this type of cancer is treated.",
author = "Moghaddam, {Maysam Amin} and Tam{\'a}s Perlaky and Kriszti{\'a}n Kov{\'a}cs and J{\'a}nos Kiss and Kriszti{\'a}n Szalay and I. Antal and Z. S{\'a}pi and M. Szendrői",
year = "2017",
month = "12",
day = "18",
language = "Hungarian",
volume = "61",
pages = "368--373",
journal = "Magyar Onkologia",
issn = "0025-0244",
publisher = "Akademiai Kiado",
number = "4",

}

TY - JOUR

T1 - A lágyrészszarkóma epidemiológiája egy hazai egyetemi centrumban

AU - Moghaddam, Maysam Amin

AU - Perlaky, Tamás

AU - Kovács, Krisztián

AU - Kiss, János

AU - Szalay, Krisztián

AU - Antal, I.

AU - Sápi, Z.

AU - Szendrői, M.

PY - 2017/12/18

Y1 - 2017/12/18

N2 - Our aim was to investigate the rare malignant soft tissue sarcomas responsible for 1.5% of all malignant tumors, to compare our epidemiological data from the patient population of the Department of Orthopaedics, Semmelweis University, to data described in the international literature for soft tissue tumors. We reviewed 595 cases of primary soft tissue sarcomas treated between 1994 and 2014 and compared results to international data from the literature. Our results were similar to those found in the international literature: mean age, mild male predominance, the most common sarcoma subgroups, the superficial and deep sarcoma ratio, low and high grade sarcoma ratio, the ratio of patients with a primary lung metastasis. Compared to other European data we found significantly longer patient referral to centers (3.6 months in case of superficial sarcomas, 8 months in case of deep localization) which surprisingly had no substantial effect on average tumor size (superficial: 5 cm, deep: 10.5 cm). This corresponds with data from the literature. The long delay period in patients' request of medical service draws attention to difficulties in differential diagnosis in this rare type of tumor, delays in referring patients to a center, and the lack of consultation. We recommend that the required investigations be performed in a musculoskeletal oncology center where this type of cancer is treated.

AB - Our aim was to investigate the rare malignant soft tissue sarcomas responsible for 1.5% of all malignant tumors, to compare our epidemiological data from the patient population of the Department of Orthopaedics, Semmelweis University, to data described in the international literature for soft tissue tumors. We reviewed 595 cases of primary soft tissue sarcomas treated between 1994 and 2014 and compared results to international data from the literature. Our results were similar to those found in the international literature: mean age, mild male predominance, the most common sarcoma subgroups, the superficial and deep sarcoma ratio, low and high grade sarcoma ratio, the ratio of patients with a primary lung metastasis. Compared to other European data we found significantly longer patient referral to centers (3.6 months in case of superficial sarcomas, 8 months in case of deep localization) which surprisingly had no substantial effect on average tumor size (superficial: 5 cm, deep: 10.5 cm). This corresponds with data from the literature. The long delay period in patients' request of medical service draws attention to difficulties in differential diagnosis in this rare type of tumor, delays in referring patients to a center, and the lack of consultation. We recommend that the required investigations be performed in a musculoskeletal oncology center where this type of cancer is treated.

UR - http://www.scopus.com/inward/record.url?scp=85066462423&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85066462423&partnerID=8YFLogxK

M3 - Article

VL - 61

SP - 368

EP - 373

JO - Magyar Onkologia

JF - Magyar Onkologia

SN - 0025-0244

IS - 4

ER -